Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Influenza A virus | Nonstructural protein 1 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Hypothetical protein | Nonstructural protein 1 | 230 aa | 202 aa | 23.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Schistosoma mansoni | hypothetical protein | 0.0199 | 0.4014 | 0.3805 |
Toxoplasma gondii | LsmAD domain-containing protein | 0.0058 | 0.1023 | 0.8236 |
Schistosoma mansoni | aspartate carbamoyltransferase | 0.0033 | 0.0474 | 0.0141 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0058 | 0.1023 | 0.5 |
Schistosoma mansoni | cpg binding protein | 0.0034 | 0.0498 | 0.0166 |
Mycobacterium tuberculosis | Probable bifunctional purine biosynthesis protein PurH: phosphoribosylaminoimidazolecarboxamide formyltransferase (AICAR transfo | 0.025 | 0.5109 | 0.5 |
Echinococcus granulosus | Ataxin 2 N terminaldomain containing protein | 0.0026 | 0.0338 | 0.0335 |
Echinococcus multilocularis | tumor protein p63 | 0.0351 | 0.7266 | 0.7266 |
Brugia malayi | CXXC zinc finger family protein | 0.0034 | 0.0498 | 0.4873 |
Trypanosoma brucei | PAB1-binding protein , putative | 0.0058 | 0.1023 | 0.5 |
Onchocerca volvulus | 0.0051 | 0.0876 | 1 | |
Plasmodium vivax | ataxin-2 like protein, putative | 0.0058 | 0.1023 | 1 |
Leishmania major | hypothetical protein, conserved | 0.0058 | 0.1023 | 1 |
Schistosoma mansoni | cpg binding protein | 0.0036 | 0.0539 | 0.0209 |
Echinococcus multilocularis | Ataxin 2, N terminal,domain containing protein | 0.0026 | 0.0338 | 0.0335 |
Schistosoma mansoni | hypothetical protein | 0.048 | 1 | 1 |
Mycobacterium leprae | Probable bifunctional purine biosynthesis protein PurH : phosphoribosylaminoimidazolecarboxamide formyltransferase (aicar transf | 0.025 | 0.5109 | 0.5 |
Echinococcus multilocularis | dnaJ subfamily B | 0.048 | 1 | 1 |
Echinococcus granulosus | tumor protein p63 | 0.0351 | 0.7266 | 0.7266 |
Mycobacterium ulcerans | bifunctional phosphoribosylaminoimidazolecarboxamide formyltransferase/IMP cyclohydrolase | 0.025 | 0.5109 | 1 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0058 | 0.1023 | 1 |
Brugia malayi | hypothetical protein | 0.0038 | 0.0583 | 0.5696 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0071 | 0.1303 | 0.0999 |
Schistosoma mansoni | hypothetical protein | 0.0199 | 0.4014 | 0.3805 |
Loa Loa (eye worm) | hypothetical protein | 0.0058 | 0.1023 | 1 |
Toxoplasma gondii | histone lysine methyltransferase SET1 | 0.0064 | 0.114 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0051 | 0.0876 | 0.8567 |
Plasmodium falciparum | ataxin-2 like protein, putative | 0.0058 | 0.1023 | 1 |
Schistosoma mansoni | cpg binding protein | 0.0036 | 0.0539 | 0.0209 |
Schistosoma mansoni | hypothetical protein | 0.0054 | 0.0927 | 0.0609 |
Wolbachia endosymbiont of Brugia malayi | AICAR transformylase/IMP cyclohydrolase PurH | 0.025 | 0.5109 | 1 |
Loa Loa (eye worm) | CXXC zinc finger family protein | 0.0034 | 0.0498 | 0.4859 |
Echinococcus granulosus | cpg binding protein | 0.0036 | 0.0539 | 0.0537 |
Echinococcus multilocularis | geminin | 0.0199 | 0.4014 | 0.4013 |
Echinococcus multilocularis | cpg binding protein | 0.0036 | 0.0539 | 0.0537 |
Brugia malayi | hypothetical protein | 0.0058 | 0.1023 | 1 |
Trypanosoma cruzi | PAB1-binding protein , putative | 0.0058 | 0.1023 | 0.5 |
Schistosoma mansoni | cellular tumor antigen P53 | 0.0051 | 0.0876 | 0.0558 |
Echinococcus granulosus | geminin | 0.0199 | 0.4014 | 0.4013 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 5.0119 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of HADH2 (Hydroxyacyl-Coenzyme A Dehydrogenase, Type II). (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.